Senate Confirms Susan Monarez as CDC Director Amidst Agency Overhaul and Funding Concerns
Susan Monarez has been confirmed as the new CDC director, the first under a 2023 law, amidst proposed funding cuts and an agency overhaul.
Overview
- Susan Monarez was confirmed by the U.S. Senate as the new CDC director, becoming the first to undergo Senate confirmation under a 2023 law.
- Monarez, with a Ph.D. in microbiology and immunology, breaks the tradition of medical doctors leading the CDC, bringing decades of experience in public health.
- Her confirmation comes as President Trump proposes significant cuts, over 40%, to the CDC's funding for fiscal year 2026, impacting agency operations.
- The CDC is undergoing an overhaul by HHS Secretary Robert F. Kennedy Jr., who has shaped policies, including removing COVID-19 vaccine recommendations for healthy children.
- During her hearing, Monarez rejected the vaccine-autism link but did not commit to challenging Kennedy's vaccine policies, amidst Senate questions.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources frame the story by emphasizing the challenging environment Monarez inherits, portraying the CDC as "in chaos" and "reeling" from cuts. They highlight the perceived conflict between Monarez's scientific background and Secretary Kennedy Jr.'s "mistrust of the scientific and medical establishment," suggesting her role will involve balancing core scientific values with the administration's controversial stances.
"Monarez has been serving as the acting head of the CDC since January, and previously worked as the head of the Advanced Research Projects Agency for Health."
CBS News"Monarez inherits an agency reeling from deep staffing cuts, funding clawbacks and a clampdown on communications."
NPRArticles (7)
FAQ
Susan Monarez holds a Ph.D. in microbiology and immunology and has nearly two decades of experience in various government roles, including at the Department of Health and Human Services, Department of Homeland Security, and White House Office of Science and Technology Policy. She has led innovative projects at ARPA-H, focusing on public and population health challenges such as affordability, accessibility, behavioral and mental health, and tackling epidemics, as well as data innovation including AI and machine learning applications.
Unlike previous CDC directors who were typically medical doctors, Susan Monarez does not have clinical medical experience but instead brings extensive scientific expertise and high-level experience in managing complex federal public health systems and innovation strategies, which aligns with operational leadership needs of the CDC.
The CDC is facing significant funding cuts proposed by President Trump, over 40% reduction for fiscal year 2026, which could impact agency operations. Additionally, the agency is undergoing an overhaul led by HHS Secretary Robert F. Kennedy Jr., including controversial changes to vaccine policies like removing COVID-19 vaccine recommendations for healthy children, creating a challenging environment for Monarez's leadership.
During her confirmation hearing, Susan Monarez rejected the discredited autism-vaccine link but did not commit to challenging Secretary Kennedy's vaccine policies, including the removal of COVID-19 vaccine recommendations for healthy children, despite Senate questions.
History
- This story does not have any previous versions.